RGC: Regencell Bioscience – Investigational Liquid-Formula RGC-COV19™ Shows Promise in Eliminating COVID-19 Symptoms
By Beth Senko, CFA
NASDAQ:RGC
DSS: DSS Starts to Generate Revenues From New Ventures and Hits Cash Flow Breakeven in Q4
By Lisa Thompson
NYSE:DSS
READ THE FULL DSS RESEARCH REPORT
MNOV: Genzyme Patent Litigation Could Lead to Significant Payout…
By David Bautz, PhD
NASDAQ:MNOV
READ THE FULL MNOV RESEARCH REPORT
VQS: Revenue Growth, Margin Expansion Anticipated
By M. Marin
NASDAQ:VQS | TSX:VQS
READ THE FULL VQS RESEARCH REPORT
MITI: Mitesco, Inc. – A Great Set-Up for 2022
By Beth Senko, CFA
OTC:MITI
READ THE FULL MITI RESEARCH REPORT
Sleep Apnea—A Plague for America with More Help on the Way
By Brad Sorensen, CFA
OTC:RSPI | NASDAQ:IXHL
ENSC: Ensysce Releases Encouraging Financials
By Brad Sorensen, CFA
NASDAQ:ENSC
READ THE FULL ENSC RESEARCH REPORT
CLSN: DSMB Recommends Continuing to Dose Patients in OVATION 2 Study…
By David Bautz, PhD
NASDAQ:CLSN
READ THE FULL CLSN RESEARCH REPORT
GBS: Institutional Review Board Approval for Glucose
By John Vandermosten, CFA
NASDAQ:GBS
READ THE FULL GBS RESEARCH REPORT
LGVN: LGVN Publishes Positive Alzheimer’s Results
By Brad Sorensen, CFA
NASDAQ:LGVN
READ THE FULL LGVN RESEARCH REPORT